Tuesday 28 January 2020 ,
Tuesday 28 January 2020 ,
Latest News
  • Wage social movement against drugs, President to students
  • West Bengal Assembly passes resolution against CAA
  • Dhaka City Polls: BNP’s Tabith unveils election manifesto
  • Community-based prevention measures important to curbing pneumonia spread: China health authorities
  • 2 of a family die after ‘mysterious fever’ in Munshiganj
  • Afghan passenger plane crashes in Taliban-held eastern area
  • China virus toll leaps to 80 despite massive lockdown
26 August, 2019 00:00 00 AM

New drug for people who can bleed uncontrollably

BBC News Health
New drug for people who can bleed uncontrollably

A daily pill containing four medicines can cut the number of heart attacks and strokes by a third, a study shows.

The polypill contains blood-thinning aspirin, a cholesterol-lowering statin and two drugs to lower blood pressure.

The researchers - in Iran and the UK - said the pill had a huge impact but cost just pennies a day.

They suggest giving it to everyone over a certain age in poorer countries, where doctors have fewer options and are less able to assess individuals.

Coronary heart disease and stroke are the top two causes of death worldwide, killing more than 15 million people a year.

Smoking, obesity and doing little exercise all increase the risk of an unhealthy heart.

The study, published in the Lancet, was based in more than 100 villages in Iran and about 6,800 people took part.

Half the people were given the polypill and advice on how to improve their lifestyle, with the other half just getting the advice.

After five years there were:

202 major cardiovascular events in the 3,421 people getting the polypill

301 in the 3,417 not getting the pill

At this rate, giving the preventative drug combination to 35 people would prevent one of them developing a serious heart problem over the course of five years.

"We've provided evidence in a developing or middle-income country - and that's a lot of countries - that this is a strategy worth considering," Professor Tom Marshall, from the University of Birmingham, told BBC News.

The polypill led to large reductions in bad cholesterol but had only a slight effect on blood pressure, the study showed.

The drug was given to people over the age of 50 whether they had had a previous heart problem or not.

 

A third of Britons with high blood pressure were unaware they have the condition

"Given the polypill's affordability, there is considerable potential to improve cardiovascular health and to prevent the world's leading cause of death," said Dr Nizal Sarrafzadegan, of Isfahan University of Medical Sciences, Iran.

The idea of the polypill has been around since 2001 but this is the first major trial to prove its effectiveness.

In the UK and other wealthier countries doctors have the time to assess the needs of individual patients and a wide choice of different drugs, such as statins, to chose from.

"In the UK, the advantages would be more marginal and you would probably want a clinical trial to see any benefits over what is offered at the moment," said Prof Marshall.

The drug is also not licensed in the UK and would be tricky to get approved.

The British Heart Foundation said a third of Britons with high blood pressure were unaware they have the condition.

"This means that the biggest priority in the UK is to identify more people who do not realise they have high blood cholesterol or high blood pressure and to help people prescribed medications to take them as prescribed," the charity said.

 

Comments

Most Viewed
Digital Edition
More story
Editor Speaks

Editor Speaks

Leprosy or Hensen’s Disease is an infectious, chronic granulomatus disease caused by an acid and alcohol fast bacillus called Micobacterium Leprae.…
Q&A on Leprosy

Q&A on Leprosy

What is leprosy? Leprosy is a chronic, progressive bacterial infection caused by the bacterium Mycobacterium leprae. It primarily affects the nerves of…
Leprosy elimination

Leprosy elimination

Leprosy is a chronic infectious disease caused by Mycobacterium leprae, an acid-fast, rod-shaped bacillus. The disease mainly affects the skin, the peripheral…
Global Leprosy Strategy 2016-2020

Global Leprosy Strategy 2016-2020

The past three decades have witnessed some impressive advances in leprosy control. Elimination as a public health problem (i.e. registered prevalence…
Sepsis: Everything you need to know

Sepsis: Everything you need to know

Sepsis is a life-threatening illness caused by body's response to an infection. This infection injures its own tissues and organs, potentially leading…
Mystery virus in Wuhan identified as novel coronavirus

Mystery virus in Wuhan identified as novel coronavirus

Chinese authorities have been commended for the speed at which they have identified the genetic make up of a novel coronavirus, 2019-nCoV as the cause…
Belly fat linked with repeat heart attacks

Belly fat linked with repeat heart attacks

Heart attack survivors who carry excess fat around their waist are at increased risk of another heart attack, according to research published today in…
5 Things to do after your child is diagnosed with autism

5 Things to do after your child is diagnosed with autism

KACIE After my daughter was diagnosed with autism, I learned five important lessons I want to pass on to other families. There is a lot more to this list…
BAUS Conf 2020

BAUS Conf 2020

14th  BAUS Conference 2020 of Bangladesh Association of Bangladesh Association of Urological Surgeons was held at Intercontinental Hotel, Dhaka on…
'Alarming' one in five deaths due to sepsis

'Alarming' one in five deaths due to sepsis

JAMES GALLAGHER   One in five deaths around the world is caused by sepsis, also known as blood poisoning, shows the most comprehensive analysis of…
FDA warns of surgical gowns that may not be sterile

FDA warns of surgical gowns that may not be sterile

Certain surgical gowns and surgical packs made by Cardinal Health may not be sterile and should not be used, the U.S. Food and Drug Administration said…
FDA approves Ozempic (semaglutide) for cardiovascular risk reduction in adults with Type 2 Diabetes and known heart disease

FDA approves Ozempic (semaglutide) for cardiovascular risk reduction in adults with Type 2 Diabetes and known heart disease

Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Ozempic (semaglutide) injection 0.5 mg…

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting